Advancing Orthobiologics to Enhance the Body’s Ability to Heal

Who We Are

Our mission is to partner with the health care community to help people resume and enjoy active lives.  To this end, we develop and/or market clinically proven and cost-effective orthobiologic solutions for bone healing, bone graft and osteoarthritis that are backed by clinical data.

What We’re Known For

Bioventus’ products are known for their safety, innovation, and effectiveness. The company focuses its medical product development around two segments Bioventus Active Healing Therapies and Bioventus Surgical.

The Bioventus Active Healing Therapies product line supports accelerated and more complete healing of bone fractures, and treats the chronic pain associated with osteoarthritis. Our bone healing solutions work to enhance the body’s natural healing process, thereby accelerating recovery and improving the patient’s quality of life. Our injection therapies that treat osteoarthritic joints relieve pain and help bring mobility back to the patient. Our therapies may also reduce the need for invasive procedures, leading to more cost-effective outcomes than previously possible.

Bioventus Surgical is driven to advance the science and surgical performance of orthobiologics with a comprehensive portfolio of clinically efficacious and cost effective solutions.

Our offerings will expand to meet market demand to improve healing and contain healthcare costs.

How We Got Here

Established in 2012, Bioventus is privately held and headquartered in Durham, NC. The company has more than 700 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands.

Bioventus also has offices in Memphis, TN; Australia and Canada. In addition, it has a research and development site located in Boston. In 2018, products from Bioventus will help more than 400,000 people regain active lifestyles. It works with patients, payers and health care providers in 30 countries throughout the world and generates $300 million dollars in annual revenue.

References

1. Internal company revenue data.